A systematic review of 29,941 patients shows that preoperative MRI findings significantly improve risk stratification for men with prostate cancer undergoing radical prostatectomy.

AI enhanced MRI improves prostate cancer detection accuracy, outperforming traditional methods and supporting better diagnosis.

Prostate cancer kills more than 12,000 men a year in the UK, slightly more than the number of women who die from breast cancer.

Lucida Medical has raised £8.7m to power its ‘same-day’ cancer diagnosis. IW Capital has invested in the Cambridge healthtech ...

Lucida’s software is designed to identify prostate cancer ‘within minutes’ and overcome diagnosis delays associated with ...

The campaign for better prostate cancer awareness has provoked important questions about the lack of testing and screening. Why are men dying unnecessarily?

Leading figures from the world of business and sport, including Sir Chris Hoy and Sir Tom Hunter, have urged tens of ...

Men don’t have to die from prostate cancer. It’s a matter of making them aware. When I first found out about it, and that this is a cancer that can be ...

And it's poised to now offer even more data. Prenuvo is launching a new bloodwork component to complement its full-body MRI ...

'The more men who get tested, the better' ...

The first men have taken part in a major UK trial testing new ways to screen for prostate cancer and detect the disease earlier ...

Test Now Incorporates Enhanced Machine Learning Risk Prediction Algorithm Plans Underway to Commercialise Testing Service Through Trinity Biotech’s New York Reference Laboratory DUBLIN and NEW YORK, ...